Trending Content
Career Resources
WSO Free Modeling Series - Now Open Through
May 31, 2024
9 Free Financial Modeling Lessons
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
+Bonus: Get 27 financial modeling templates in swipe file
+Bonus: Get 27 financial modeling templates in swipe file
Probably not overvalued. The problem is that its trading at ~$40 and the FDA comments are imminent (Beginning of May). If approved, the stock will probably jump ~20%, or so to about $48-55, but if it is not approved you will see a 65-75% decrease. Look at Medivation for example (MDVN). MDVN went from $40 to $13 in one day, its currently at $11. If you are unfamiliar, MDVD fell over 70% in one day (March 3, 2010) when its Phase III results for Alzheimer's came back completely shitty.
I would be careful as there is little upside and a ton of downside.
Grad....are you buying?
Et exercitationem ut non voluptas aut placeat modi. Tempore blanditiis dolorum debitis culpa. Et occaecati eaque non. Non ea et maxime et suscipit tempore. Quos excepturi atque repudiandae sequi et numquam sunt.
Voluptates asperiores nisi dolor. Reprehenderit qui quasi quis consequatur sit minus maxime. Nostrum nostrum iste omnis porro. Sed debitis fuga qui est. Officia magni eligendi temporibus rerum veniam molestiae dolore adipisci. Repellat et est voluptatum.
Porro est voluptatibus est perspiciatis. Et provident a inventore.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...